SITADOSE-DM FORTE

MRP
399/- Strip

Description
Each film-coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate IP eq. to Dapagliflozin 10 mg, Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg, Metformin Hydrochloride IP 1000 mg (in extended-release form), Excipients q.s.

Doses
As directed by the physician.

Indication
Dapagliflozin + Sitagliptin is used in the treatment of type 2 diabetes mellitus. This combination of two antidiabetic medications works by reducing blood glucose levels. Dapagliflozin increases urinary glucose excretion, while Sitagliptin helps control blood sugar by regulating insulin production and reducing glucose production in the liver.